Skip to main content

Table 1 Chronogram and investigations of the ARPEGE study

From: Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE)

  Inclusion Weekly follow-up during RT 3 months after RT Once/year during the 5 first years Every 2 years during the 10 next first End of study (15 years)
Written Informed consent signature X             
Checking of inclusion and non-inclusion criteria X             
Inclusion X             
Clinical exam X X X X X X X X X X X X X
Medical history X             
Biopsy X             
Blood sample X             
Toxicity recording   X X X X X X X X X X X X
Biopsy-related adverse events recording   X X X X X X X X X X X X
Blood sample-related adverse events recording   X X X X X X X X X X X X
Concurrent treatments recording X X X X X X X X X X X X X